Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity Meeting Abstract
| Authors: | Lopes, E. C.; Shieh, J. H.; Ambati, S.; Tsann-Long, S.; Correa, F.; Peguero, E.; Moore, M. A. S. |
| Abstract Title: | Novel alkylating agent, ureidomustine exhibit pre-clinical efficacy in B-cell lymphoma with minimal dose-limiting myelotoxicity |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368019005034 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.1556.1556 |
| Notes: | Meeting Abstract: 1556 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
